Special Enrollment Period (SEP)

A Special Enrollment Period (SEP) is a time outside of the normal enrollment period during which an individual can enroll in or make changes to their health insurance coverage. This is typically allowed only in certain circumstances, such as changes in life circumstances that impact a person's insurance coverage.

Here are some key features of a Special Enrollment Period:

  • Qualifying life events: SEP is typically granted when certain life events happen, such as loss of job-based coverage, getting married or divorced, having a baby or adopting a child, or moving to a new state.
  • Time limits: SEP is typically allowed for a limited period of time, usually 60 days from the qualifying event.
  • Application process: To take advantage of SEP, individuals must submit an application during the SEP period and provide documentation of the qualifying event.
  • Plan options: During the SEP period, individuals may be able to select a new health insurance plan or make changes to their existing plan.
  • Coverage effective dates: The effective date of coverage for a SEP application may vary depending on the qualifying event and the date the application is submitted.

For example, if an individual loses their job and their job-based health insurance coverage ends, they may be eligible for SEP to enroll in a new health insurance plan. The individual would need to submit an application within 60 days of losing their job-based coverage and provide documentation of the qualifying event. Once the application is approved, the individual can select a new health insurance plan, with coverage effective from the date of the job loss.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.